Skip to main content
Before choosing courseBB2450 The Cell Factory 7.5 creditsAdministrate About course

This course focuses on the exploitation of microorganisms and eukaryotic cellular systems and their biochemical pathways for the synthesis and modification of products at an industrial scale. Het is de interface tussen biochemie, microbiologie, eukaryote celbiologie en schaal-up / industriële bioprocessen. It exploits the basic knowledge from the Biochemistry and Microbiology courses from the second year and serves as a basis for the "Energy and Environment" and "Bioprocess Design" courses proposed at the end of the 4th year and during the 5th year.

Choose semester and course offering

Choose semester and course offering to see information from the correct course syllabus and course offering.

* Retrieved from Course syllabus BB2450 (Spring 2020–)

Content and learning outcomes

Course contents

  • Prokaryotic and eukaryotic cell structure, including plant and mammalian cells, and cellular compartment functions, including sub-cellular localization of specific metabolic pathways
  • Specific prokaryotic and eukaryotic pathways for the production of complex biomolecules, including cellulose, alginate, chitins, glycoproteins and fatty acids, etc.
  • Describe prokaryotic and eukaryotic cell factories, including special features of eukaryotic hosts, such as codon usage, post-translational modifications, protein folding, protein processing, of disulfide bond formation
  • Metabolic engineering of fungi and plant systems, including transformation system (e.g. plastid targeting, Agrobacterium)- emphasis on carbohydrate polymers, plasticizer, lipid-derivatives, and punctually on biofuel production
  • Exploitation on other cell factory systems, such as algal system, and their metabolic pathways for the bioproduction.
  • Describe new technologies in synthetic biology, and how this has impact in bioproduction 
  • Cost-benefit analysis (including environmental and social economical impact) for the sustainable production in the pathways specific/certain types of organisms which the products have potential applications
  • Process of mammalian cell-based system (e.g. Chinese Hamster Ovary cells, HEK293) for the manufacturing of biologics Development of mammalian cell-based processes, fed-batch and perfusion, aimed at commercial production for the production of biopharmaceuticals including scale-up aspects, requirements of patient safety and compliance to regulatory constraints
  • Demonstration of fed-batch bioreactor process using Chinese Hamster Ovary cell for the production of monoclonal antibody

Intended learning outcomes

On completion of the course (ILOs), the students should be able to:

  • Describe and differentiate microorganisms and eukaryotic cellular systems, including mammalian cells, and their biochemical pathways.
  • Discuss with reference to scientific literature the challenges and potential opportunities in using genetically engineered cell factories for the production of biopharmaceuticals/biomolecules/chemicals/fuels at an industry scale.
  • Design a cell factory approach to the production of a given product, with reference to supporting scientific literature.
  • Design a cultivation process using mammalian cell system for the production of biologics fit for industrial purpose, i.e. robust and reproducible process using appropriate mammalian cell line and expression system, integrating scale-up constraints, Good Manufacturing Practice (GMP), and awareness of patient safety, as well as describe and discuss how such a process is developed
  • Design, evaluate, execute and present in written form an independent laboratory project report.

Course Disposition

No information inserted

Literature and preparations

Specific prerequisites

 BB1100 Biochemistry laboratory or equivalent

Recommended prerequisites

- BB1100 Biochemistry laboratory or equivalent

- BB2020 Molecular enzymology or equivalent

Equipment

No information inserted

Literature

No information inserted

Examination and completion

If the course is discontinued, students may request to be examined during the following two academic years.

Grading scale

A, B, C, D, E, FX, F

Examination

  • KON1 - Intermediate Exam 1, 1,0 hp, betygsskala: P, F
  • KON2 - Intermediate Exam 2, 1,0 hp, betygsskala: P, F
  • NÄR1 - Mandatory Participation at Lectures, 1,0 hp, betygsskala: P, F
  • TEN1 - Written Exam, 4,5 hp, betygsskala: A, B, C, D, E, FX, F

Based on recommendation from KTH’s coordinator for disabilities, the examiner will decide how to adapt an examination for students with documented disability.

The examiner may apply another examination format when re-examining individual students.

Opportunity to complete the requirements via supplementary examination

No information inserted

Opportunity to raise an approved grade via renewed examination

No information inserted

Examiner

Profile picture Yves Hsieh

Ethical approach

  • All members of a group are responsible for the group's work.
  • In any assessment, every student shall honestly disclose any help received and sources used.
  • In an oral assessment, every student shall be able to present and answer questions about the entire assignment and solution.

Further information

Course web

Further information about the course can be found on the Course web at the link below. Information on the Course web will later be moved to this site.

Course web BB2450

Offered by

CBH/Chemistry

Main field of study

Biotechnology

Education cycle

Second cycle

Add-on studies

No information inserted

Contact

Yves Hsieh (yhsieh@kth.se)

Supplementary information

Studenter er forpligtet til at tilmelde sig mindst to uger i forvejen for eksamen.

The course is given provided at least seven students are admitted.